Contribution of Oxidized Low Density Lipoprotein and Nitric Oxide in the Pathogenesis of Early Onset Acute Myocardial Infarction in Egyptian population.

Slides:



Advertisements
Similar presentations
Tobias Reichlin, W. Hochholzer, C. Stelzig, K. Laule, M. Potocki, K
Advertisements

Journal Reading Myocardial infarction in young people Cardiol J 2009; 16, 4: 307–311 Cardiol J 2008; 15: 21–25 Presented by R 王郁菁 at ER conference.
Dr Verity Blackwell West Hertfordshire Dermatology Team.
Authors: Sujai M. Parker, Gunjan N. Jodi, Jalak Jani
Overly concerning and falsely reassuring?? FRAMINGHAM RISK FACTORS IN THE ED.
Only You Can Prevent CVD Matthew Johnson, MD. What can we do to prevent CVD?
 Transports nutrients and removes waste from the body.  Supplies blood and oxygen to the body.
IDF-EMME Region Meeting September 7-9, 2007 Cairo, Egypt.
Acute Coronary Syndrome. Acute Coronary Syndrome (ACS) Definition of ACS Signs and symptoms of ACS Gender and age related difference in ACS Pathophysiology.
Global impact of ischemic heart disease World Heart Federation, 2011.
1 What is… ? Disparities Among Women in Acute Cardiac Care Frances Canet, MD Cath Conference Thursday, May 26, 2011.
What Is Cholesterol? Cholesterol is a type of fat (or lipid). It is found in blood and body cells. Some cholesterol is made by the body, and some is consumed.
20 Cardiovascular Disease and Physical Activity chapter.
Donald Grandis, M.D,. A Real Life Case Presentation M.F. is a 64 year old woman with no history of high blood pressure, diabetes mellitus, high cholesterol,
Lower levels of ADAMTS13 are associated with cardiovascular disease by Supakanya Lasom Master Degree Student of Medical Sciences, Bongers T.N, Bruijne.
SERUM VISFATIN CONCENTRATION IS ASSOCIATED WITH AN ATHEROGENIC METABOLIC PROFILE T.D. Filippatos 1, A. Liontos 1, F. Barkas 1, E. Klouras 1, V. Tsimihodimos.
AN ASSESSMENT OF THE PRIMARY PREVENTION CONTROL PROGRAM OF PHC PREVENTIVE CARDIOLOGY CLINIC AMONG PATIENTS AT RISK FOR CVD: A Retrospective Cohort Study.
Health Disparities of Minority Women and Diabetes Kathleen M. Rayman, Ph.D., RN Appalachian Center for Translational Research in Disparities Faculty Development.
Author: Moldovan Carmen Co-authors: Opincariu Diana Balan Daniel University of Medicine and Pharmacy Tg. Mures Cardiology Clinic, Mures Emergency Clinical.
Relationship between total cholesterol and 90-day mortality after acute myocardial infarction in patients not on statins Rishi Parmar 2 nd year Medicine.
Association of C-Reactive Protein and Acute Myocardial Infarction in HIV-Infected Patients Virginia A. Triant, MD, MPH, James B. Meigs, MD, MPH, and Steven.
CASE STUDY 2 DATENAME MARCH 2, 2011 SAMIA B. Epidemiology of Cardiovascular Disease/Coronary Artery Disease.
Community Outreach to Reduce Disparities in Cardiovascular & Diabetes Morbidity & Mortality in the South Bronx Michael Alderman, MD Michelle Johnson, MD,
SERUM LEVELS OF TISSUE INHIBITOR OF METALLOPROTEINASE-2 AND OX-LDL ARE ASSOCIATED WITH ATHEROSCLEROSIS IN PATIENTS WITH CΗRONIC KIDNEY DISEASE Grigorios.
>>0 >>1 >> 2 >> 3 >> 4 >> Human Diseases Presentation: Myocardial Infarction (MI) Maria Maqsood.
Cardiovascular Disease
Erica Duffy Cardiology Patients  Medically supervised program  Educational Program  Improves health of those with heart disease and other cardiovascular.
Dr. Nadira Mehriban. INTRODUCTION Diabetic retinopathy (DR) is one of the major micro vascular complications of diabetes and most significant cause of.
TAHAR EL KANDOUSSI, SARA ECHERKI, NAWAL DOGHMI, MOHAMED CHERTI. SEcurite de l’Echocardiographie de stress : plutôt l’effort. Cardiology B Department, Ibn.
Troponin By Julie Moore C Dt204/2.
Template provided by: “posters4research.com” Levels of fasting blood glucose (p
INTRODUCTION & OBJECTIVES Introduction: The carcinogenesis of hepatocellular carcinoma (HCC) is a multifactorial, multistep and complex process. Its prognosis.
Correlation of Glu298Asp eNOS Polymorphism with Serum NO Levels in Egyptian Coronary Artery Disease Patients Sahar Abdel-Maksoud, Sally Ibrahim, Feeby.
Inflammatory Bowel Disease Is Associated With an Increased Incidence of Cardiovascular Events Andres J. Yarur, MD, Amar R. Deshpande, MD, David M. Pechman,
Indication Contraindication Preparation
Nonalcoholic Fatty Liver Disease and Risk of Future Cardiovascular Events Among Type 2 Diabetic Patients Giovanni Targher, Lorenzo Bertolini, Felice Poli,
Cardiovascular Disease: Risk Factors and Risk Assessment
Alcohol, Other Drugs, and Health: Current Evidence July–August 2017
The role of unknown risk factors in coronary heart disease
Jakutis G.1, Polevoda V.1, Serpytis R.2, Serpytis P.2,3
Results from the intermountain heart collaborative study
Non-metabolic syndrome mean (DS) Metabolic syndrome mean (DS)
Arabinda Mohan Bhattarai, MBBS, MD (Biochemistry) Asst Prof, NAIHS
. Troponin limit of detection plus cardiac risk stratification scores for the exclusion of myocardial infarction and 30-day adverse cardiac events in ED.
Journal of Nuclear Cardiology | Official Journal of the American Society of Nuclear Cardiology Artificial Neural Network based model enhances risk.
The Value of Measurement of Circulating Tumor Cells in Hepatocellular Carcinoma Nashwa Sheble, Gehan Hamdy, Moones A Obada, Gamal Y Abouria, Fatma Khalaf.
Dr. Syed Waleem Pasha Assistant Professor Yenepoya Medical College
Elevated Circulating Levels of Inflammatory Markers in
Patient clinical characteristics (n=123)
Diagnostic characteristics and prognoses of primary-care patients referred for clinical exercise testing: a prospective observational study Nilsson G1,
Mrs. Watcharasa Pitug ID
Phenotype vs. Genotype: Defining Severe Familial Hypercholesterolemia
The IDEAL Study Reference
Prevalence and Impact of Anxiety Disorders in
Tpeak-Tend for arrhythmic or mortality risk stratification in Ischemic Heart Disease: a meta-analysis Ka Hou Christien Li 1, Mengqi Gong BS 2, Wing Tak.
Investigating Polymorphisms in the NADSYN1/DHCR7 Locus (rs and rs ) as Novel Genetic Markers for Cardiovascular Disease Sally I. Hassanein,
Prevalence and control of cardiovascular risk factors using a German sample – Findings from the STAAB Cohort Study Theresa Tiffe1,3, Götz Gelbrich1,2,
Heart Rate, Life Expectancy and the Cardiovascular System: Therapeutic Considerations Cardiology 2015;132: DOI: / Fig. 1. Semilogarithmic.
Jagadesh M ,SURYA NARAYANA J, JAYAPRAKASH, NRRAU
Effects of High Density Lipoprotein Raising Therapies on Cardiovascular Outcomes in Patients with Type 2 Diabetes Mellitus, with or without Renal Impairment:
Neil J. Stone et al. JACC 2014;63:
Rhematoid Rthritis Respiratory disorders
A: Epidemiology update
An example of the Lancet
Ongoing statin therapy at hospitalization for acute myocardial infarction. Learnings for general practitioners. Ghena Shabana Specialist in Family Medicine.
Baseline Characteristics of the Subjects*
Heart Disease Dr Stasinos Theodorou
Internal Medicine Workshop Series Laos September /October 2009
Preventative Cardiology
Presentation transcript:

Contribution of Oxidized Low Density Lipoprotein and Nitric Oxide in the Pathogenesis of Early Onset Acute Myocardial Infarction in Egyptian population Ingy M. Hashad1 , Mohamed F. Abdel Rahman1, Laila K. Effat 2, Khalda S. Amr2, Nabil M. Farag3, Mohamed Z. Gad1 1 Clinical Biochemistry Unit, Faculty of Pharmacy and Biotechnology, the German University in Cairo, Egypt 2 Department of Medical Molecular Genetics, National Research Center, Giza, Egypt 3 Department of Cardiology, Faculty of Medicine, Ain Shams University, Cairo, Egypt Background: Subjects & Methods: Myocardial infarction (MI) is the leading cause of death for both genders worldwide. The molecular mechanisms for the pathogenesis of MI, however, remain to be fully elucidated. Control Subjects: Random unrelated 101 healthy subjects were recruited. Information on personal and family medical history and health-relevant behaviors, including exercise and diet was obtained by a routine questionnaire filled in by blood donors at the time of venesection. AMI Patients: Random unrelated 104 AMI patients were recruited from the intensive care unit of El Demerdash Hospital, Cairo, Egypt. Exclusion criteria included any concomitant acute or chronic severe diseases such as renal failure, hepatic insufficiency, chronic cardiovascular disease, diabetes mellitus and age above 55. Risk factors for atherosclerosis & MI: 1- Smoking 2- High blood pressure 3- Diabetes 4- High Cholesterol 5- Gender 6- Obesity 7- Depression 8-Metabolic syndrome Fig. (5): Serum levels of NO in control & AMI subjects. Fig. (6): Serum levels of ox-LDL in control & AMI subjects. r = 0.199 P = 0.047 r = 0.351 P = 0.0003 Table (1): The general characteristics of control & AMI subjects. Data are expressed as mean ± SEM. Groups Control AMI Number (M/F) 101 (70/31) 104 (69/35) Age (years) M: 28.44 ± 0.94 F: 28.65 ± 1.95 M: 46.8 ± 0.73 F: 45.23 ± 1.07 Fig. (8): Correlation between serum NO and TC levels in AMI   Fig. ( 7): Correlation between serum NO and TC levels in controls   Fig. (1) : Stages of myocardial infarction Fig. (2) : Stages of atherosclerosis in cross section of artery r = 0.252 P = 0.017 r = 0.337 P = 0.001 Diagnosis of Myocardial Infarction: Methods: Serum Ox-LDL levels were determined quantitatively using ELISA technique. Serum NO levels were determined calorimetrically by Griess method. Results: Fig. (9): Correlation between serum ox-LDL and TC levels in AMI Fig. (10):Correlation between serum ox-LDL and NO levels in AMI Conclusions: ECG changes indicatives of MI Severe chest pain Cardiac Enzyme Markers Association of oxidative stress and inflammation, represented by ox-LDL and NO respectively, with the incidence of AMI. Objectives: Investigate the contribution of oxidative stress, represented by Oxidized low density liopprotein (ox-LDL), in the development of acute myocardial infarction (AMI). Predict the role of inflammation, represented by nitric oxide (NO), in the pathogenesis of early onset AMI. Correlate these biochemical markers together . References: Clinical Biochemistry: An illustrated colour text, A. Gaw et al., Churchill Livingstone. Clinical Chemistry: Interpretation and Techniques, A. Kaplan & L.L. Szabo, Lea & Febiger, Philadelphia. This study was supported financially by Science and Technology Development (STDF) Fund , Grant No. 2951. Fig. (3): Serum levels of TG in control & AMI subjects. Fig. (4): Serum levels of TC in control & AMI subjects.